Jolanta Kaczmarek Selected Research

Jolanta Kaczmarek Research Topics

2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2016 - 01/2013
2	Water Intoxication 01/2015 - 01/2015
2	Neoplasms (Cancer) 01/2003 - 01/2002
1	Inflammation (Inflammations) 09/2020
1	Weight Loss (Weight Reduction) 08/2016
1	Heart Failure 01/2015
1	Renal Insufficiency (Renal Failure) 01/2015
1	Insulin Resistance 01/2013
1	Obesity 01/2013
1	Carcinogenesis 03/2008
1	Body Weight (Weight, Body) 03/2008
1	Breast Neoplasms (Breast Cancer) 09/2002
1	Squamous Cell Carcinoma of Head and Neck 01/2002
1	Neoplasm Metastasis (Metastasis) 01/2002

2	LipidsIBA 08/2016 - 01/2013
2	LDL glycated lipoproteinsIBA 08/2016 - 01/2013
2	Metformin (Glucophage)FDA LinkGeneric 08/2016 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 09/2002
2	AlbuminsIBA 01/2015 - 01/2015
2	CholesterolIBA 01/2015 - 01/2015
1	HDL CholesterolIBA 09/2020
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 08/2016
1	hydroxide ionIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Natriuretic PeptidesIBA 01/2015
1	Troponin T (Troponin T1)IBA 01/2015
1	Hemoglobins (Hemoglobin)IBA 01/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013
1	Insulin (Novolin)FDA Link 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	Lipoproteins (Lipoprotein)IBA 01/2013
1	AcidsIBA 03/2008
1	MethylcholanthreneIBA 03/2008
1	PhenolsIBA 03/2008
1	XenobioticsIBA 03/2008
1	Tannic Acid FDA Link 03/2008
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2002
1	Biological ProductsIBA 01/2002
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2002

2	Therapeutics 08/2016 - 01/2013
1	Renal Dialysis (Hemodialysis) 01/2015
1	Aftercare (After-Treatment) 01/2003